Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-20T01:16:29.577Z Has data issue: false hasContentIssue false

Selenium status in very old adults: Insights from the Newcastle 85+ Study

Published online by Cambridge University Press:  24 May 2023

G. Perri
Affiliation:
Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne,
J.C. Mathers
Affiliation:
Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne,
C. Martin-Ruiz
Affiliation:
Ageing Research Laboratories, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne
J.S. Walsh
Affiliation:
Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK
R. Eastell
Affiliation:
Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK
L. Schomburg
Affiliation:
Institute for Experimental Endocrinology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
L. Robinson
Affiliation:
Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne,
T. R. Hill
Affiliation:
Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne,
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2023

It is well-known that selenium intakes are suboptimal in older adults in the UK, however, less is known about selenium status and the relationships between biomarkers of selenium status in very old adults (≥ 85 years). We aimed to assess biomarkers of selenium status among 85-year-old participants, and to quantify the relationship between serum selenium and selenoproteins, glutathione peroxidase (GPx3) and selenoprotein P (SePP).

Biomarkers of selenium status (serum selenium, GPx3 activity and SePP) were measured using standard laboratory techniques (benchtop total reflection x-ray fluorescence (TXRF), coupled-enzyme reaction measuring nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) consumption and immunoluminometric, commercial enzyme-linked immunosorbent assay (ELISA), respectively) in 757 participants from The Newcastle 85+ Study. Biomarkers of selenium status concentrations were assessed and compared to cut-offs based on selenium DRVs. The cut-offs used were 70 μg/l for serum selenium, 115 U/L for GPx3 and 4.5 mg/l for SePP based on the respective previous literature (Reference Nève1,Reference Demircan, Bengtsson and Sun2,Reference Hughes, Fedirko and Jenab3) . Linear equations were plotted between serum selenium and the two selenoproteins (GPx3 and SePP) to assess the relationship.

The median concentrations (IQR) were serum selenium 53.6 (23.6) μg/l, GPx3 activity 142.1 (50.7) U/L, and SePP 2.9 (1.9) mg/l. There was a strong, positive linear, the relationship between serum selenium and GPx3 activity (y = 90.79 + 0.97*x; R2 = 0.132 P < 0.001) and SePP (y = 0.99 + 0.04*x; R2 = 0.247 P < 0.001). Based on the literature and derived cut-offs for selenium adequacy, the selenium status of this very old population is inadequate, especially regarding serum selenium (82% below 70 μg/l) and SePP (83% below 4.5 mg/l). In contrast, GPx3 activity appears to be sufficient when compared to other British cohorts.

In this population of very old adults, selenium status was suboptimal, especially the biomarkers, serum selenium and SePP. There were linear associations between serum selenium and the selenoproteins, suggesting expression was not optimised. The implications of this low selenium status are currently being explored in this cohort.

Acknowledgments

I would like to say a big thank you to all my supervisors, Prof. Tom Hill, Prof. John Mathers, Prof. Richard Eastell and Dr. Jennifer Walsh, for their time, support and input. I would also like to thank the wider Newcastle 85+ Study team, especially Dr. Nuno Mendonca for his statistical knowledge, and Dr. Carmen Martin-Ruiz for helping me prepare The Newcas-tle 85+ Study samples for analyses. I would also like to thank Prof. Lutz Schomburg and his research team: Prof. Petra Seeman; Kamil Demircan; Thilo Chillon; Julian Hackler; Qian Sun; and Sophie Jahn, at Charité, Universi-tätsmedizin Berlin for allowing a collaboration and analysing the biomarkers of selenium sta-tus, as well as welcoming me on an insightful visit to their laboratory in Berlin.

References

Nève, J (1995) J Trace Elem Med Biol, 9, 6573.10.1016/S0946-672X(11)80013-1CrossRefGoogle Scholar
Demircan, K, Bengtsson, Y, Sun, Q et al. (2021) Redox Biol, 47, 102145.10.1016/j.redox.2021.102145CrossRefGoogle Scholar
Hughes, DJ, Fedirko, V, Jenab, M et al. (2015) Int J Cancer, 136, 11491161.10.1002/ijc.29071CrossRefGoogle Scholar